IJSRP, Volume 4, Issue 11, November 2014 Edition [ISSN 2250-3153]
Dr Neha Goyal, Dr Tushar Palve, Dr Aditi Parmar
Pregnancy is a special phase in every woman’s life and demands special care because even a small mishap can turn this happy journey in to a scary nightmare. That’s why treating any ailment including malignancy merits special consideration as it can have a long lasting impact on two lives. Hodgkins lymphoma is one of the common malignancy encountered during pregnancy and chemotherapy plays a central role in its management. Chemotherapeutic drugs with their toxic effects can have a profound effect on the outcome of pregnancy. Keeping this view in mind we report our experience of treating such patient in a tertiary care hospital and try to highlight the challenges involved. Lymphoma is a rare diagnosis in pregnancy. Chemotherapy and radiotherapy during the first trimester is associated with fetal malformation risk which diminishes as pregnancy advances. In view of relative rarity of such cases there is a critical need for multicentre cooperation and a central registry to collect data on such cases and their follow up so that treating physicians could assess more accurately the safety of different chemotherapeutic agents in pregnancy.